课题基金 / 基金详情

Developement of pediatric size ventricular assist device for therapeutic use in profound heart failure after open heart surgery.

Developement of pediatric size ventricular assist device for therapeutic use in profound heart failure after open heart surgery.
开发儿童尺寸的心室辅助装置,用于心脏直视手术后严重心力衰竭的治疗。
批准号:
59870047
负责人:
NAKATANI Takeshi
金额:
$2.37万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Developmental Scientific Research
财政年份:
1984
资助国家:
日本
项目状态:
已结题
起止时间:
1984 至 1985

项目摘要

项目成果

NAKATANI Takeshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In children as in adults, there are many patients who develop profound heart failure after open heart surgery. Since IABP and veno-arterial bypass are not effective and complicated, more effective and safer cardiac assistance is needed. So we have developed pediatric size air-driven and diaphragm type ventricular assist device(VAD) for children. Its stroke volume is 20 ml and it is made of segmented polyether polyurethane(TOYOBO TM-series) and contains two #21 Bjork-Shiley valves. The conduits are made of polyvinylchloride and their inner surface is coated with TM-3. The IDs of inlet and outlet conduet are 6 and 8 mm. The control drive unit is the same as that developed for adult use in our center.In vitro performance demonstrated that the pump could yield sufficient flow and had a good ability to follow tachycardia.The results of the chronic animal experiments using young goats(body weight: 9-17 kg) indicated that VAD for children had excellent in vivo performance in several aspects. These included ease of implantation, sufficient capability for circulrtory support, good antithrombogenicity, high durability and no harm on the blood chemistry of young and immature animals.And we had one clinical case. He was 3 year-old boy and operation was done for ventricular septal defect. After that he could not be weaned from extracorporeal circulation, so this VAD was applied.The entire circulation was well maintained and he was weaned from VAD after 3 days pumping because of his heart recovery.So we believe this VAD can be an effective and safe approach for treating the child with postoperative profound heart failure.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
人工臓器. 16. (1986)
人造器官。16。(1986)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Trans Am Soc Artif Intern Organs. 30 : 155. (1984)
Trans Am Soc Artif 实习生器官。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Jpn J Artif Organs. 15. (1986)
Jpn J Artif 器官。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Development of artificial niche matrices for cardiac differentiation of stem cells
Novel neointima-inducing treatment of acellular small-diameter blood vessel for good patency
Development of an observation system for hydrothermal area using an autonomous underwater vehicle
A novel injectable peptide-based hydrogel for myocardial infarction treatment
海外基金